Cargando…
AF.27 COVID-19 VACCINE: A SURVEY ON HESITANCY IN PATIENTS WITH CELIAC DISEASE
Autores principales: | Costantino, A., Topa, M., Roncoroni, L., Lombardo, V., Stocco, D., Gramegna, A., Costantino, C., Maurizio, V., Elli, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editrice Gastroenterologica Italiana S.r.l.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451185/ http://dx.doi.org/10.1016/S1590-8658(21)00590-9 |
Ejemplares similares
-
AF.49 DETERMINANTS OF COVID-19 VACCINE HESITANCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): RESULTS OF A NATIONAL SURVEY OF THE ITALIAN IBD PATIENTS’ ASSOCIATION (AMICI ONLUS)
por: Costantino, A., et al.
Publicado: (2021) -
AF.93 COVID-19 IN LIVER TRANSPLANT RECIPIENTS: AN ITALIAN CASE-CONTROL DOUBLE-CENTER STUDY
por: Guarino, M., et al.
Publicado: (2021) -
AF.78 THE PARADOX OF COVID-19 PANDEMIC: EFFECT OF LOCKDOWN ON THE IMPROVEMENT OF IRRITABLE BOWEL SYNDROME SEVERITY
por: Andreozzi, M., et al.
Publicado: (2021) -
AF.53 THE LEGACY OF COVID-19 PANDEMICS: REMOTE MONITORING OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE AS AN EFFECTIVE MANAGEMENT STRATEGY
por: Busacca, A., et al.
Publicado: (2021) -
AF.51 VEDOLIZUMAB MAY BE AN EFFECTIVE OPTION FOR THE MANAGEMENT OF POSTOPERATIVE RECURRENCE OF CROHN’S DISEASE
por: Macaluso, F.S., et al.
Publicado: (2021)